AS Latvijas Juras medicinas centrs (UOM) — Cash Flow-to-Debt Ratio
AS Latvijas Juras medicinas centrs (UOM) has a Cash Flow-to-Debt Ratio of -0.26x as of December 2025, meaning its operating cash flow of €-622.30K could theoretically repay 0% of its total liabilities (€2.40 Million) in one year. See UOM cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
AS Latvijas Juras medicinas centrs Cash Flow-to-Debt Ratio (2015–2025)
Historical debt coverage capacity for AS Latvijas Juras medicinas centrs across 11 annual periods. Also explore UOM shareholders equity momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for AS Latvijas Juras medicinas centrs (2015–2025)
Year-by-year debt coverage analysis for AS Latvijas Juras medicinas centrs. For market capitalisation and broader financial context, see AS Latvijas Juras medicinas centrs (UOM) total market value.
| Year | CF-to-Debt Ratio | Operating CF (EUR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.01x | €-17.28K | €2.40 Million | ▼ -103.4% |
| 2024 | 0.21x | €605.02K | €2.88 Million | ▼ -68.7% |
| 2023 | 0.67x | €1.91 Million | €2.85 Million | ▲ +25.3% |
| 2022 | 0.54x | €1.09 Million | €2.04 Million | ▲ +145.5% |
| 2021 | 0.22x | €418.24K | €1.92 Million | ▼ -45.5% |
| 2020 | 0.40x | €732.71K | €1.83 Million | ▲ +53.4% |
| 2019 | 0.26x | €412.86K | €1.58 Million | ▼ -31.3% |
| 2018 | 0.38x | €599.57K | €1.58 Million | ▲ +15.7% |
| 2017 | 0.33x | €478.41K | €1.46 Million | ▲ +34.0% |
| 2016 | 0.25x | €418.49K | €1.71 Million | ▲ +15.2% |
| 2015 | 0.21x | €362.36K | €1.70 Million | — |